Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9609 posts found.

Ian Read image

Poll: UK opposed to Pfizer takeover bid of AZ

May 13, 2014 Research and Development, Sales and Marketing AstraZeneca, Cameron, Pfizer, UK, buyout, merger, research

The UK’s largest union says a new poll shows that the vast majority of the British public are against Pfizer’s …
News
Boehringer image

Boehringer launches new transparency regime

May 12, 2014 Research and Development, Sales and Marketing Boehringer, LEO Pharma, all trials, csr, transparency

Boehringer is making good on its 2013 promise to release more clinical trial data to researchers with the launch of …
News
david_cameron_1

AZ ‘consulted first’ by UK government after Pfizer bid

May 12, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, George Osborne, Pfizer, Wellcome Trust, david cameron

UK prime minister David Cameron has rejected claims that his government is prioritising discussions with Pfizer over its proposed acquisition …
News

Pfizer signs universities deal

May 12, 2014 Research and Development, Sales and Marketing AstraZeneca, Pfizer, academics, rare diseases

Pfizer has signed a five-year research deal with several top British universities to hunt for new treatments for rare disease. …
News
AZ park image

‘Bioscience is cornerstone’ of Alderley Park

May 12, 2014 Research and Development, Sales and Marketing AZ, AstraZeneca, alderley, msp, research

Manchester Science Parks (MSP), the new owners of the 400-acre Alderley Park facility, has pledged to keep its activities “at …
News
Lundbeck image

Lundbeck buys Chelsea Therapeutics

May 12, 2014 Research and Development, Sales and Marketing Chelsea Therapeutics, Lundbeck

Lundbeck could pay as much as $658 million for neurological disorder specialist Chelsea Therapeutics as the firm looks to shore …
News
Riwal image

Clinical trials transparency: the journey so far

May 12, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, NHS, alltrials, rawal, transparency

There has been considerable publicity over the last year or two about transparency of information in clinical trials. However, activity …
Feature
christian_lebbink

Talentmark hires Benelux executive search head

May 12, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Talentmark, lebbink

Life sciences recruitment firm Talentmark has confirmed Christiaan Lebbink is to join the firm covering the Benelux and continental European region Lebbink, …
Appointment
astrazeneca_plaque

AstraZeneca begins lung cancer trial

May 9, 2014 Research and Development, Sales and Marketing AstraZeneca, Cancer, MEDI4736, NSCLC, lung cancer

AstraZeneca, currently at the centre of a £63 billion bid from US giant Pfizer, has begun a late-stage trial of …
News
screen_shot_2014-05-09_at_08

ABPI appoints manager 
from Pfizer


May 9, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Pfizer, christine rowland

The ABPI has appointed Christine Rowland to the newly-created position of value and access manager for its commercial department.  Rowland …
Appointment
daniel_smith_high_res

Cobra Biologics appoints CSO


May 8, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CSO, cobra biologics, smith

Contract manufacturing organisation Cobra Biologics has hired Dr Daniel Smith as its chief scientific officer. Smith has spent the last …
Appointment
NHS image

RPS: ‘Give pharma incentives’

May 8, 2014 Research and Development, Sales and Marketing NHS, RPS, rare diseases, royal pharmaceutical society

Incentives are urgently required to speed up the development of personalised medicines, according to a new report from the Royal …
News
screen_shot_2014-05-07_at_15

ICON appoints non-executive director

May 7, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ICON, brady

Contract research organisation (CRO) ICON has appointed Dr Hugh Brady as a non-executive director.  Brady previously served as president at …
Appointment
cancer image

Global cancer drug spend slows

May 7, 2014 Medical Communications, Research and Development, Sales and Marketing Cancer, IMS, spending

Spending on cancer drugs worldwide is slowing, according to a new report from the IMS Institute for Healthcare Informatics. The …
News

US cancer docs warn of rising drug prices

May 7, 2014 Research and Development, Sales and Marketing ASCO, Cancer, NICE, Obama, US, United States, republicans

American cancer doctors are warning that the rising price of oncology medicines is making it unaffordable for the country’s healthcare …
News
The Gateway to Local Adoption Series

Latest content

Sandoz launches allergy relief nasal spray in Germany and Switzerland

April 9, 2026

Japan approve Daiichi Sankyo’s Enhertu as a second-line treatment for gastric cancer

April 9, 2026

Trelleborg to take part in Medtec Japan 2026

April 8, 2026

Kainova Therapeutics expands phase I/II trial of antibody drug

April 7, 2026

Eisai starts enrolment for phase 2 narcolepsy study evaluating E2086

April 7, 2026